Product Description
Overall, the global peripheral thrombus management market was valued at $859 million in 2023. This is expected to increase over the forecast period at a CAGR of 9.7% to reach $1.6 billion.
Throughout this medical market research, we analyzed over 17 peripheral thrombus management companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for peripheral thrombus management extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Peripheral Thrombus Management Market Insights
Global Embolic Protection Device Market Share Insights
In 2008, MEDRAD’s acquisition of Possis brought the AngioJet® mechanical thrombectomy device into its portfolio, renowned for disrupting emboli using pressurized saline. Boston Scientific later acquired AngioJet® in May 2014, establishing its widespread use in venous and arterial thrombectomy procedures. Alongside this, in 2019, Boston Scientific further expanded its reach by acquiring the BTG EKOS® thrombectomy device, specifically tailored for PE thrombectomy. Despite not being utilized in AV therapy procedures, this strategic acquisition is expected to enhance the company’s dominance in the thrombectomy market by consolidating its product portfolio.
In contrast, Inari Medical swiftly gained a substantial market share through its ClotTriever® and FlowTriever® devices, both capable of independent use without thrombolytics. This unique attribute significantly reduced treatment times for patients. The FlowTriever®, sanctioned in 2018, became the second approved device exclusively designed for PE treatment and captured a significant market share due to its premium pricing relative to EkoSonic®. Meanwhile, ClotTriever® addresses the rapidly growing market related to peripheral vasculature, particularly in deep vein thrombosis (DVT) treatment. Inari Medical’s innovative approach positions the company strongly for further expansion and market share growth.
Penumbra specializes exclusively in the traditional thrombectomy market segment. It offers the INDIGO® CAT®, Separator®, and Pump MAX™ product families primarily for use in arterial and venous applications. The INDIGO® CAT® and Separator catheters work in conjunction with the Pump MAX™ console, which, however, is not covered in this analysis.
Market Segmentation Summary
- Traditional Thrombectomy Devices
- Pharmacomechanical Thrombectomy Devices
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
